ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #2,254Hybrid

Cellular Oncology

Acronym:ceon
•
Abbreviation (ISO):CELL ONCOL
•
Identifier (ISSN):2211-3428(Print)/2211-3436(Online)
•
Publisher:Springer Netherlands
Clarivate IF (2026)
5.6↑ +0.8
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2020–2026)

Clarivate IF trend for Cellular Oncology

WoS Q2
358105.320206.7320217.0520226.620234.820255.62026
Annual Impact Factor Metric
Current (2026):5.6
Scopus SJR & RankScopus Q1
1.561
#2,254

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
68

68 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate2%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
74articles/year
51.69% Gold OA•81.73% Original Research

Aims & Scope

The Official Journal of the International Society for Cellular Oncology Focuses on translational research Addresses the conversion of cell biology to clinical applications Cellular Oncology publishes scientific contributions from various biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level, technical and bioinformatics developments in this area, and clinical applications. This includes a variety of fields like genome technology, micro-arrays and other high-throughput techniques, genomic instability, SNP, DNA methylation, signaling pathways, DNA organization, (sub)microscopic imaging, proteomics, bioinformatics, functional effects of genomics, drug design and development, molecular diagnostics and targeted cancer therapies, genotype-phenotype interactions. A major goal is to translate the latest developments in these fields from the research laboratory into routine patient management. To this end Cellular Oncology forms a platform of scientific information exchange between molecular biologists and geneticists, technical developers, pathologists, (medical) oncologists and other clinicians involved in the management of cancer patients. In vitro studies are preferentially supported by validations in tumor tissue with clinicopathological associations.

Topics Covered (Recognized by AI)
Genetics96.4%Medicine96.4%Biology96.4%Biochemistry89.3%Chemistry89.3%Internal medicine85.7%Gene75%Cancer75%Pathology67.9%Cancer research60.7%Immunology32.1%Oncology28.6%Immunohistochemistry25%Cell biology21.4%Molecular biology21.4%DNA21.4%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CELL BIOLOGY

Q2
Rank68/207
IndexSCIE
JCRSCIE2026

ONCOLOGY

Q1
Rank74/333
IndexSCIE
JCRSCIE2026

PATHOLOGY

Q1
Rank5/89
IndexSCIE
JCISCIE2026

CELL BIOLOGY

Q1
Rank47/207
IndexSCIE
JCISCIE2026

ONCOLOGY

Q1
Rank70/333
IndexSCIE
JCISCIE2026

PATHOLOGY

Q1
Rank20/89
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

7 year
2026Latest
IF5.6
Articles / Year—
Total Citations—
2025
IF4.8
Articles / Year—
Total Citations—
2023
IF6.6
Articles / Year—
Total Citations—
2022
IF7.051
Articles / Year—
Total Citations—
2021
IF6.73
Articles / Year—
Total Citations—

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,254Scopus Q1SCImago Profile
Scopus Coverage:2011-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
1.561

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
5.47

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,575 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,834
3-Year Documents337
Citable Documents334

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1
Molecular MedicineQ1
OncologyQ1
Cancer ResearchQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
3区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cellular Oncology (acronym: ceon, abbr: CELL ONCOL, ISSN: 2211-3428) is a peer-reviewed international scholarly journal in the field of Biochemistry, published by Springer Netherlands in Netherlands since 2011. The periodical holds a Journal Impact Factor (JIF) of 5.60, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.561 (Q1), an H-index of 68.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 74 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,575 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer Netherlands
Publication Language
English
Frequency
Bimonthly
Founding Year
2011
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
IOS PRESS, NIEUWE HEMWEG 6B, AMSTERDAM, NETHERLANDS, 1013 BG

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: b0747ed2-0290-4aa7-bf04-740a70a60ea5
Database Updated: 2026-10-01